Welcome to our dedicated page for Option Care Health news (Ticker: OPCH), a resource for investors and traders seeking the latest updates and insights on Option Care Health stock.
News about Option Care Health, Inc. (OPCH) centers on its role as the nation’s largest independent provider of home and alternate site infusion services and on its regular financial and corporate updates. The company issues detailed quarterly earnings releases, often accompanied by Form 8-K filings, that cover net revenue, net income, earnings per share, and non-GAAP metrics such as Adjusted EBITDA, Adjusted net income and Adjusted diluted EPS.
Investors following OPCH news will see announcements of preliminary and final quarterly and full-year financial results, as well as updated financial guidance ranges for net revenue, Adjusted EBITDA and Adjusted diluted earnings per share. These releases typically include management commentary on performance, cash flow from operations, stock repurchase activity and capital structure developments.
Option Care Health also uses news releases to communicate capital allocation decisions, such as expansions of its share repurchase program authorization, and to describe amendments to its credit agreements that affect term loans and revolving credit facilities. SEC Form 8-K filings referenced in the news provide additional detail on these material definitive agreements and financial obligations.
Corporate governance and leadership changes are another recurring news theme. For example, the company has announced a Chief Financial Officer transition, outlining the incoming CFO’s background, compensation arrangements and the outgoing CFO’s advisory role. News items also highlight Option Care Health’s participation in major healthcare and finance conferences, including events hosted by J.P. Morgan, UBS, Jefferies, Deutsche Bank and Bank of America, with webcasts and presentation materials made available to investors.
In addition, Option Care Health appears in partner company releases, such as Quince Therapeutics’ announcements of a strategic relationship for specialty infusion therapy support. These items describe how Option Care Health’s national network of specialty pharmacies and ambulatory infusion suites may be used to administer specific infused therapies, particularly in rare disease indications. For ongoing coverage of these financial, strategic and operational developments, OPCH news on this page aggregates company press releases, partner announcements and related disclosures.
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., is set to present at the 39th Annual J.P. Morgan Healthcare Conference on January 11, 2021, at 3:40 p.m. EST. CEO John Rademacher and CFO Mike Shapiro will lead the presentation. A replay will be available on their investor relations site. With over 5,000 employees, including 2,900 clinicians, Option Care Health is committed to improving care standards for patients with various conditions across all 50 states.
On December 10, 2020, Option Care Health (NASDAQ: OPCH) announced that an affiliate of Madison Dearborn Partners will sell 10,000,000 shares of its common stock at $15.00 per share in an underwritten public offering. The offering, expected to close on December 14, 2020, includes a 30-day option for the underwriter to purchase an additional 1,500,000 shares. This sale reduces the Selling Stockholder’s interest from 70.6% to 64.5%. Option Care Health will not receive any proceeds from this transaction.
Option Care Health (NASDAQ: OPCH) announced that an affiliate of Madison Dearborn Partners plans to sell 10,000,000 shares of its common stock in an underwritten public offering. The Selling Stockholder has granted the underwriter a 30-day option to purchase an additional 1,500,000 shares. Following this offering, the Selling Stockholder's ownership will decrease from 70.6% to 64.5%. Goldman Sachs & Co. LLC is the sole underwriter for this offering, which the Company will not benefit from financially.
Option Care Health, Inc. (Nasdaq: OPCH) reported financial results for Q3 2020, revealing a 27% increase in net revenue to $781.6 million from $615.9 million in Q3 2019. Gross profit rose to $174.2 million (22.3% of revenue), compared to $137.8 million (22.4%). The company recorded a net income of $1.7 million or $0.01 per share, a significant recovery from a $42.8 million loss last year. Adjusted EBITDA surged by 70% to $59.2 million, with operational cash flow improving to $48.3 million from a loss of $5.8 million.
Option Care Health (NASDAQ: OPCH) will release its third-quarter results for the period ending September 30, 2020, on November 3, 2020, before market opening. Following the results, a conference call is scheduled at 8:30 AM ET for management to discuss the findings. Investors can join the call via phone or a live audio webcast, with a replay available for approximately 90 days. As the largest independent provider of home and alternate site infusion services in the U.S., Option Care Health continues to elevate patient care standards.
Option Care Health (NASDAQ: OPCH), the largest independent provider of home and alternate site infusion services in the U.S., announced its participation in the Lake Street 4th Annual Best Ideas Growth Conference on September 17, 2020. Chief Financial Officer Mike Shapiro is scheduled for one-on-one meetings with investors during this virtual event. With over 5,000 teammates, including around 2,900 clinicians, Option Care Health aims to elevate care standards for patients with both acute and chronic conditions nationwide.
Option Care Health (NASDAQ: OPCH) has been chosen to join the limited distribution network for VILTEPSO™ (viltolarsen), an innovative treatment for Duchenne Muscular Dystrophy (DMD). This therapy, the first exon 53 skipping treatment approved by the FDA, shows promise for increasing dystrophin levels in young patients. Option Care Health will provide home and ambulatory infusion services for VILTEPSO across its facilities in the U.S. The company is recognized for its quality clinical care and commitment to enhancing patient outcomes.
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., will participate in two upcoming virtual investor conferences. CFO Mike Shapiro will present at the Baird 2020 Global Healthcare Conference on September 10, 2020, at 3:10 p.m. EDT. CEO John Rademacher and CFO Mike Shapiro will present at the Morgan Stanley 18th Annual Healthcare Conference on September 14, 2020, at 9:45 a.m. EDT. Live audio webcasts will be available on their investor relations website.
Option Care Health, the largest independent provider of home and alternate site infusion services in the U.S., will present at the 40th Annual Canaccord Genuity Virtual Growth Conference on August 12, 2020, at 10:00 a.m. EST. CEO John Rademacher and CFO Mike Shapiro will lead the presentation. A live audio webcast and a replay will be available at here. With over 5,000 teammates across the nation, Option Care Health focuses on enhancing care standards for patients with various conditions.
Option Care Health announced an underwritten offering of 18,000,000 shares of its common stock at $12.50 per share. The offering includes 10,000,000 shares from the Company and 8,000,000 shares from a Madison Dearborn Partners affiliate. Underwriters have a 30-day option for 2,700,000 additional shares. Proceeds will partially repay senior secured second lien PIK toggle notes due 2027. Closing is expected on July 24, 2020. BofA Securities leads the offering with several firms acting as bookrunners.